Author - Kevin Costa

Five must-dos for potential biotech start-ups

Thinking about a biotech start-up? James Currier, a four-time VC-backed CEO and manager of NFX’s biotech fund, shares his valuable advice. This article is brought to you by NFX, a Silicon Valley based venture firm that...

What — and who — is synthetic biology?

If you ask three synthetic biologists, “What is synthetic biology?”, you are likely to get four, maybe five or more answers. So what is it? Simply put, synthetic biology is an engineering approach to biology...

Join our team of talented writers and columnists

SynBioBeta seeks a few great writers/columnists to help build a world-class content team in synthetic biology. Writers will be assigned specific topics for 500- to 750-word articles about people, companies, technology...